Deliverable D2.2 is instrumental for WP2, as it presents and defines the testing methodology that will be applied within 5GMED pre-testing and full trials phases. In addition, this deliverable presents the potential deployment location and options across trial sites. This deliverable also presents an initial set of test cases related to the different use cases and networks to assess their performances.

The deliverable is used as input to WP3, WP4 and WP5 to derive the infrastructure’s initial requirements and the CCAM and FRMCS applications.